Prevalence and clinical significance of liver function abnormalities in patients with acute heart failure

Klaudia Vyskocilova1, Lenka Spinarova1, Jindrich Spinar2

  • 11st Department of Internal Medicine - Cardioangiology, St. Anne's University Hospital in Brno, International Clinical Research Center and Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Insights

Abnormal liver function tests (LFTs) are common in acute heart failure (AHF), affecting 76% of patients. LFT patterns correlate with AHF severity and type, aiding diagnosis and management.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cardiac dysfunction can lead to liver pathology, but its clinical significance in acute heart failure (AHF) requires further evaluation.
  • Understanding liver involvement in AHF is crucial for accurate diagnosis and effective patient management.

Purpose of the Study:

  • To determine the prevalence of abnormal liver function tests (LFTs) in patients with AHF.
  • To identify factors associated with hepatic impairment in AHF patients.

Main Methods:

  • Utilized data from the AHEAD (Acute Heart Failure Database) registry, including 1473 AHF patients.
  • Analyzed baseline serum activities of LFTs and total bilirubin.

Main Results:

  • 76% of AHF patients exhibited abnormal LFTs, with variations in specific enzyme elevations.
  • LFT abnormalities were linked to AHF severity (e.g., left ventricular ejection fraction, NYHA class) and clinical presentation.
  • Distinct LFT patterns (hepatocellular vs. cholestatic) were associated with different types of AHF and tricuspid regurgitation severity.

Conclusions:

  • Characterizing LFT profiles in AHF is important for clinical management.
  • Identifying typical LFT patterns can prevent unnecessary hepatic investigations and diagnostic errors in AHF patients.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K